Welcome to our dedicated page for Ingredion SEC filings (Ticker: INGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingredion Incorporated filings document the formal disclosures of a NYSE-listed ingredient solutions company with common stock registered under the ticker INGR. Its 8-K reports include operating results, financial-condition updates, dividend-related corporate actions, leadership changes, board appointments and governance matters.
The company's proxy materials cover director elections, executive compensation, board structure, shareholder voting items and non-management director compensation. Other filings describe capital-structure details for its common stock, exit or disposal activities, impairment charges, restructuring matters and risk disclosures connected to manufacturing operations and the company's plant-based ingredient portfolio.
Ingredion Incorporated provided an update on its planned all-cash acquisition of the entire issued and to be issued ordinary share capital of Tate & Lyle PLC. Tate & Lyle has published a Scheme Document under UK law, explaining the court-sanctioned scheme of arrangement that will be used to implement the deal.
Tate & Lyle will send this document to its shareholders ahead of a Court Meeting and a General Meeting scheduled for July 28, 2026, where shareholders will vote on the scheme and related resolutions. The disclosure emphasizes that this is not an offer or solicitation in itself and that shareholders should base any voting decisions solely on the information in the Scheme Document.
Escoe T. Kenneth reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director T. Kenneth Escoe received a grant of 1,516 restricted stock units as part of the company’s outside director annual equity retainer. The RSUs, which may be settled in one share of common stock each, are valued at $98.97 per unit and will vest on May 19, 2027, aligning compensation with the annual stockholder meeting cycle.
Ingredion Inc director T. Kenneth Escoe has filed an initial insider ownership report on Form 3. This filing identifies him as a director and a reporting person subject to insider disclosure rules. The report does not list any specific share holdings or recent transactions.
Magro Charles V. reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director Charles V. Magro reported a compensation-related grant of 265 phantom stock units on June 30, 2026. The units were allocated in lieu of a cash retainer under the company’s Non-Qualified Deferred Compensation Plan, using the closing price of $94.71 per share that day.
Each phantom stock unit represents the right to receive one share of Ingredion common stock in the future. Following this award, Magro holds a total of 500 phantom stock units directly, reflecting deferred, non-cash compensation rather than an open-market purchase.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc reported that SVP, Global Operations and CSCO David Eric Seip received a grant of phantom stock as part of his compensation. On June 30, 2026, he was awarded 18.44 phantom stock units, valued using the $94.711 closing price of Ingredion common stock that day.
Each phantom stock unit represents the right to receive one share of common stock under the company’s Non-Qualified Deferred Compensation Plan. Following this award, Seip holds a total of 13,236.1041 phantom stock units, reflecting his accumulated deferred compensation position rather than an open-market stock purchase or sale.
Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president Michael J. Leonard reported a compensation-related award of phantom stock units. On June 30, 2026, he was granted 36.066 phantom stock units based on a closing common share price of $94.71, increasing his total phantom stock holdings to 1,718.846 units. Each phantom stock unit represents the right to receive one share of Ingredion common stock under the company’s Non-Qualified Deferred Compensation Plan, so this filing reflects deferred equity-based compensation rather than an open-market stock purchase or sale.
Ingredion Incorporated has completed the previously announced sale of 51% of the issued share capital of Rafhan Maize Products Co. Ltd. to a purchaser group led by Nishat Hotels and Properties Limited for approximately $165 million in cash, received in U.S. dollars.
Rafhan Maize generated about $250 million of net sales in 2025 and is not in a reportable segment. As part of the deal, the purchasers acquired roughly 78% of Rafhan Maize’s outstanding shares, while Ingredion retained an approximate 20% minority ownership interest. A shareholders agreement grants Ingredion a put option exercisable beginning in the fifth year after closing, and new manufacturing, supply, and distribution agreements will support ongoing product flows between Ingredion and Rafhan Maize.
Ingredion Incorporated entered into a new senior unsecured delayed draw term loan facility totaling $1,475,000,000 to help finance its planned acquisition of Tate & Lyle PLC, refinance certain Tate & Lyle debt, and pay related fees and expenses.
The facility is split into a $500,000,000 Tranche A-1 maturing three years after funding and a $975,000,000 Tranche B-1 maturing five years after funding, each amortizing at 5% per year in quarterly payments. Interest is based on a base rate or SOFR plus margins linked to Ingredion’s credit ratings or leverage ratio.
The agreement includes financial covenants requiring a maximum leverage ratio of 3.5 to 1.0, with a temporary step-up to 4.0 to 1.0 after a material acquisition, and a minimum interest coverage ratio of 3.5 to 1.0. The new facility replaces in full the $1,475,000,000 tranche A commitment under Ingredion’s existing $4,225,000,000 bridge loan, leaving the $2,750,000,000 tranche B bridge commitment outstanding.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president David Eric Seip received a grant of 17.206 phantom stock units tied to the company’s common stock. The award was allocated under the Non-Qualified Deferred Compensation Plan based on the $101.5000 closing share price on June 15, 2026. Following this grant, Seip holds 13,217.6641 phantom stock units, each representing the right to receive one share of Ingredion common stock in the future.
Ingredion Inc senior vice president and CIO Michael J. Leonard reported a compensation-related award of phantom stock units. On June 15, 2026, he acquired 33.65 phantom stock units at a reference price of $101.51 per unit under the Non-Qualified Deferred Compensation Plan.
After this grant, Leonard holds a total of 1,682.78 phantom stock units directly. According to the plan, each phantom stock unit represents the right to receive one share of Ingredion common stock, based on the closing share price used for allocation.